bml-284 Search Results


95
MedChemExpress bml 284
The effects of Sestrin2 on cancer stemness are mediated by the Wnt/β-catenin pathway. A Western blot analysis of Wnt/β-catenin signaling-related proteins. The relative protein expression is shown in the right panel. β-Actin was used as a loading control * P = 0.05; Mann–Whitney test; lines showed medians). B Sphersphere formation assay in LV-Sestrin2 and LV-GFP CRC cells with or without exposure <t>to</t> <t>BML-284</t> (0.1 µM). C Number of spheres, * compared with LV-GFP, * P = 0.05; # compared with LV-Sestrin2, # P = 0.05; Mann–Whitney test; lines showed medians. D Western blot analysis of proteins related to the Wnt/β-catenin pathway (β-catenin, c-Myc) and cancer stemness (CD44) in LV-Sestrin2 and LV-GFP CRC cells with or without incubation with BML-284 (0.5 µM) for 24 h in HCT-116 cells. E The relative protein expression. * Compared with LV-GFP, * P = 0.05, # compared with LV-Sestrin2, # P = 0.05, Mann–Whitney test; lines showed medians
Bml 284, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bml-284/BML-284/pmc08840770-70-13-17
Average 95 stars, based on 1 article reviews
bml 284 - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier


90
Topscience Co Ltd wnt agonist 1 (bml-284)
The effects of Sestrin2 on cancer stemness are mediated by the Wnt/β-catenin pathway. A Western blot analysis of Wnt/β-catenin signaling-related proteins. The relative protein expression is shown in the right panel. β-Actin was used as a loading control * P = 0.05; Mann–Whitney test; lines showed medians). B Sphersphere formation assay in LV-Sestrin2 and LV-GFP CRC cells with or without exposure <t>to</t> <t>BML-284</t> (0.1 µM). C Number of spheres, * compared with LV-GFP, * P = 0.05; # compared with LV-Sestrin2, # P = 0.05; Mann–Whitney test; lines showed medians. D Western blot analysis of proteins related to the Wnt/β-catenin pathway (β-catenin, c-Myc) and cancer stemness (CD44) in LV-Sestrin2 and LV-GFP CRC cells with or without incubation with BML-284 (0.5 µM) for 24 h in HCT-116 cells. E The relative protein expression. * Compared with LV-GFP, * P = 0.05, # compared with LV-Sestrin2, # P = 0.05, Mann–Whitney test; lines showed medians
Wnt Agonist 1 (Bml 284), supplied by Topscience Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bml-284/wnt+agonist+1++wnt+signaling+activator+++bml+284++853+220+52+7+/pm39885534-86-0-11
Average 90 stars, based on 1 article reviews
wnt agonist 1 (bml-284) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
AbMole Bioscience wnt agonist bml-284
The effects of Sestrin2 on cancer stemness are mediated by the Wnt/β-catenin pathway. A Western blot analysis of Wnt/β-catenin signaling-related proteins. The relative protein expression is shown in the right panel. β-Actin was used as a loading control * P = 0.05; Mann–Whitney test; lines showed medians). B Sphersphere formation assay in LV-Sestrin2 and LV-GFP CRC cells with or without exposure <t>to</t> <t>BML-284</t> (0.1 µM). C Number of spheres, * compared with LV-GFP, * P = 0.05; # compared with LV-Sestrin2, # P = 0.05; Mann–Whitney test; lines showed medians. D Western blot analysis of proteins related to the Wnt/β-catenin pathway (β-catenin, c-Myc) and cancer stemness (CD44) in LV-Sestrin2 and LV-GFP CRC cells with or without incubation with BML-284 (0.5 µM) for 24 h in HCT-116 cells. E The relative protein expression. * Compared with LV-GFP, * P = 0.05, # compared with LV-Sestrin2, # P = 0.05, Mann–Whitney test; lines showed medians
Wnt Agonist Bml 284, supplied by AbMole Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bml-284/wnt+agonist+bml+284/pm34763437-54-1-7
Average 90 stars, based on 1 article reviews
wnt agonist bml-284 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Adooq Bioscience LLC wnt activator bml-284
a Relative expression of canonical Wnt target genes Myc, Ccnd1, Ascl2, Id2, Tcf4 and Mmp9 in C2C12 cells cultured under various conditions. b Western blot showing canonical Wnt mediator Ctnnb (β-catenin) protein level in C2-Scr and C2-shmVcl2 cells cultured as indicated. c Co-immunoprecipitation analysis showing direct vinculin and Ctnnb interaction in C2-Scr and C2-shmVcl2 cells grown under indicated conditions. d Bar graph showing RT-qPCR validation of Wnt target genes activation by canonical Wnt activator <t>BML-284</t> in C2C12 cells. e Relative expression of myogenic differentiation associated genes in C2C12 cells treated with BML-284 or vehicle in DM media shown in RT-qPCR. f Myogenic protein expression in BML-284 or vehicle treated C2C12 cells cultured under DM conditions is shown in western blot. g Representative images of Myh stain (green) and DAPI (blue) in C2C12 cells treated with BML-284 or vehicle, Scale bar 50 μM. Fusion index is shown in a bar graph. Actb act as a loading control in western blot. Data are shown as mean value ±SEM, n=3. p value * ≤0.05; **≤0.01; ***≤0.001; ****≤0.0001.
Wnt Activator Bml 284, supplied by Adooq Bioscience LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bml-284/wnt+activator+bml+284/bio_rxiv__2024__02__21__578728-231-0-5
Average 90 stars, based on 1 article reviews
wnt activator bml-284 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
CSNpharm Inc bml-284
a Relative expression of canonical Wnt target genes Myc, Ccnd1, Ascl2, Id2, Tcf4 and Mmp9 in C2C12 cells cultured under various conditions. b Western blot showing canonical Wnt mediator Ctnnb (β-catenin) protein level in C2-Scr and C2-shmVcl2 cells cultured as indicated. c Co-immunoprecipitation analysis showing direct vinculin and Ctnnb interaction in C2-Scr and C2-shmVcl2 cells grown under indicated conditions. d Bar graph showing RT-qPCR validation of Wnt target genes activation by canonical Wnt activator <t>BML-284</t> in C2C12 cells. e Relative expression of myogenic differentiation associated genes in C2C12 cells treated with BML-284 or vehicle in DM media shown in RT-qPCR. f Myogenic protein expression in BML-284 or vehicle treated C2C12 cells cultured under DM conditions is shown in western blot. g Representative images of Myh stain (green) and DAPI (blue) in C2C12 cells treated with BML-284 or vehicle, Scale bar 50 μM. Fusion index is shown in a bar graph. Actb act as a loading control in western blot. Data are shown as mean value ±SEM, n=3. p value * ≤0.05; **≤0.01; ***≤0.001; ****≤0.0001.
Bml 284, supplied by CSNpharm Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bml-284/bml+284/pm32949671-39-5-6
Average 90 stars, based on 1 article reviews
bml-284 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier


N/A
BML-284 is potent, selective and cell-permeable Wnt signaling activator. It induces β-catenin and transcription factor (TCF)-dependent transcriptional activity in 293T cells in a dose dependent manner with an EC50 of 0.7 mM in vitro.
  Buy from Supplier

N/A
Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months.ApplicationCID 11210285 has been used as a Wnt agonist
  Buy from Supplier


Image Search Results


The effects of Sestrin2 on cancer stemness are mediated by the Wnt/β-catenin pathway. A Western blot analysis of Wnt/β-catenin signaling-related proteins. The relative protein expression is shown in the right panel. β-Actin was used as a loading control * P = 0.05; Mann–Whitney test; lines showed medians). B Sphersphere formation assay in LV-Sestrin2 and LV-GFP CRC cells with or without exposure to BML-284 (0.1 µM). C Number of spheres, * compared with LV-GFP, * P = 0.05; # compared with LV-Sestrin2, # P = 0.05; Mann–Whitney test; lines showed medians. D Western blot analysis of proteins related to the Wnt/β-catenin pathway (β-catenin, c-Myc) and cancer stemness (CD44) in LV-Sestrin2 and LV-GFP CRC cells with or without incubation with BML-284 (0.5 µM) for 24 h in HCT-116 cells. E The relative protein expression. * Compared with LV-GFP, * P = 0.05, # compared with LV-Sestrin2, # P = 0.05, Mann–Whitney test; lines showed medians

Journal: Cancer Cell International

Article Title: Sestrin2 reduces cancer stemness via Wnt/β-catenin signaling in colorectal cancer

doi: 10.1186/s12935-022-02498-x

Figure Lengend Snippet: The effects of Sestrin2 on cancer stemness are mediated by the Wnt/β-catenin pathway. A Western blot analysis of Wnt/β-catenin signaling-related proteins. The relative protein expression is shown in the right panel. β-Actin was used as a loading control * P = 0.05; Mann–Whitney test; lines showed medians). B Sphersphere formation assay in LV-Sestrin2 and LV-GFP CRC cells with or without exposure to BML-284 (0.1 µM). C Number of spheres, * compared with LV-GFP, * P = 0.05; # compared with LV-Sestrin2, # P = 0.05; Mann–Whitney test; lines showed medians. D Western blot analysis of proteins related to the Wnt/β-catenin pathway (β-catenin, c-Myc) and cancer stemness (CD44) in LV-Sestrin2 and LV-GFP CRC cells with or without incubation with BML-284 (0.5 µM) for 24 h in HCT-116 cells. E The relative protein expression. * Compared with LV-GFP, * P = 0.05, # compared with LV-Sestrin2, # P = 0.05, Mann–Whitney test; lines showed medians

Article Snippet: HCT-116 cells in the LV-Sestrin2 and LV-GFP groups were treated with 0.5 μM BML-284 (Wnt signaling activator; MedChemExpress, Monmouth Junction, NJ, USA) in dimethyl sulfoxide for 24 h and then collected for western blot analysis.

Techniques: Western Blot, Expressing, Control, MANN-WHITNEY, Tube Formation Assay, Incubation

a Relative expression of canonical Wnt target genes Myc, Ccnd1, Ascl2, Id2, Tcf4 and Mmp9 in C2C12 cells cultured under various conditions. b Western blot showing canonical Wnt mediator Ctnnb (β-catenin) protein level in C2-Scr and C2-shmVcl2 cells cultured as indicated. c Co-immunoprecipitation analysis showing direct vinculin and Ctnnb interaction in C2-Scr and C2-shmVcl2 cells grown under indicated conditions. d Bar graph showing RT-qPCR validation of Wnt target genes activation by canonical Wnt activator BML-284 in C2C12 cells. e Relative expression of myogenic differentiation associated genes in C2C12 cells treated with BML-284 or vehicle in DM media shown in RT-qPCR. f Myogenic protein expression in BML-284 or vehicle treated C2C12 cells cultured under DM conditions is shown in western blot. g Representative images of Myh stain (green) and DAPI (blue) in C2C12 cells treated with BML-284 or vehicle, Scale bar 50 μM. Fusion index is shown in a bar graph. Actb act as a loading control in western blot. Data are shown as mean value ±SEM, n=3. p value * ≤0.05; **≤0.01; ***≤0.001; ****≤0.0001.

Journal: bioRxiv

Article Title: Metavinculin mediates differentiation cues into myogenic gene expression

doi: 10.1101/2024.02.21.578728

Figure Lengend Snippet: a Relative expression of canonical Wnt target genes Myc, Ccnd1, Ascl2, Id2, Tcf4 and Mmp9 in C2C12 cells cultured under various conditions. b Western blot showing canonical Wnt mediator Ctnnb (β-catenin) protein level in C2-Scr and C2-shmVcl2 cells cultured as indicated. c Co-immunoprecipitation analysis showing direct vinculin and Ctnnb interaction in C2-Scr and C2-shmVcl2 cells grown under indicated conditions. d Bar graph showing RT-qPCR validation of Wnt target genes activation by canonical Wnt activator BML-284 in C2C12 cells. e Relative expression of myogenic differentiation associated genes in C2C12 cells treated with BML-284 or vehicle in DM media shown in RT-qPCR. f Myogenic protein expression in BML-284 or vehicle treated C2C12 cells cultured under DM conditions is shown in western blot. g Representative images of Myh stain (green) and DAPI (blue) in C2C12 cells treated with BML-284 or vehicle, Scale bar 50 μM. Fusion index is shown in a bar graph. Actb act as a loading control in western blot. Data are shown as mean value ±SEM, n=3. p value * ≤0.05; **≤0.01; ***≤0.001; ****≤0.0001.

Article Snippet: Wnt activator BML-284 (5 mM) (AdooQ, USA) or inhibitor KY02111 (10 mM) (AdooQ, USA) and vehicle was treated in indicated culturing conditions and refreshed during media change.

Techniques: Expressing, Cell Culture, Western Blot, Immunoprecipitation, Quantitative RT-PCR, Activation Assay, Staining